Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
There is a widespread acceptance in the literature that plasma nonesterified fatty acids (NEFA), also called free fatty acids (FFA), can mediate many adverse metabolic effects, most notably insulin resistance. Elevated NEFA concentrations in obesity are thought to arise from an increased adipose tissue mass. It is also argued that the process of fatty acid mobilization from adipose tissue, normally suppressed by insulin, itself becomes insulin resistant—thus, lipolysis is further increased, potentially leading to a vicious cycle. Although we have also accepted this model for many years (1,2), recently there has been a steady accumulation of data, both in the literature and from our own research, that has forced us to realize that this simple story is not always true. Here we review the background to the idea of “fatty acids as metabolic villains,” together with data from the literature and from our own studies, which tend to show another side to the fatty acids/insulin resistance story. We will first examine the relationship between systemic concentrations of NEFA and obesity/insulin resistance and then study adipose tissue in the obese state with regard to its adaptation for NEFA release. NEFA circulate in the plasma bound to plasma albumin. Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health. Gordon demonstrated the origin of plasma NEFA from adipose tissue and their use by tissues such as the liver and myocardium, but not the brain. We now recognize that NEFA are the vehicle by which triacylglycerol (TG) stored in adipose tissue is transported to its sites of utilization. NEFA turnover is rapid, with a plasma half-life around 2–4 min (6). The only significant site of NEFA liberation …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The amount of liberated FFA from chylomicrons and VLDL depends on the activity of LPL, which is stimulated by insulin [17,18].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“These observations suggest that carbohydrate restriction reduces insulin secretion, which may facilitate fat mobilization (33), particularly from the intra-abdominal area, a depot associated with metabolic dysfunction that is enlarged in individuals with T2D (34,35).”
From A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705 · cited 1×
“With this approach, it is easy to show that elevated NEFA concentrations are associated acutely with insulin resistance, both with peripheral glucose uptake (33,34) and hepatic gluconeogenesis (35,36) and with impaired glucose tolerance (37).”
BackgroundA RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSE
Dole, V. P. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103259 · Cited by 3,454 · cited 1×
“Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health.”
BackgroundRomijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, E., & Wolfe, R. R. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.3.e380 · Cited by 1,747 · cited 1×
“somewhat (2), but often plasma NEFA concentrations remain relatively stable as removal by muscle increases to match adipose tissue lipolysis (27,28).”
BackgroundLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100 · cited 1×
“The detrimental effects on insulin sensitivity and other cellular processes are known as lipotoxicity (57).”
BackgroundSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · cited 1×
“The abdominal subcutaneous fat depot is the dominant source of NEFA; considerably less comes from leg adipose tissue and—against popular belief—only a small proportion of the systemic NEFA concentrations arises from intraabdominal adipose tissue (7).”
BackgroundLipolysis and lipid mobilization in human adipose tissue
Lafontan, M., & Langin, D. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.05.001 · Cited by 826 · cited 1×
“It has been reviewed recently (8), and we will not cover those aspects here.”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 2×
“The rationale for this supposition comes from the fact that adipose tissue could be seen as insulin resistant in obesity and therefore as not responding adequately to the antilipolytic action of insulin (29).”
Background
Cited by
Items 101–200 of 894
Wong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13359 · Cited by 131
“Excessive fatty acid can accumulate in skeletal muscle and impair insulin signalling pathway.([166]) The toxic lipid metabolites, including diacylglycerols, ceramides and acylCoA, are known to activate PKC and further disrupt the insulin cascade.”
BackgroundHormone-sensitive lipase: sixty years later
Recazens, E., Mouisel, É., & Langin, D. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101084 · Cited by 126
Lactylated Apolipoprotein C‐II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis
Chen, J., Zhao, D., Wang, Y., Liu, M., Zhang, Y., Feng, T., Xiao, C., Huan, S., Miao, R., Xu, L. N., et al. (2024) · Advanced Science · doi:10.1002/advs.202406333 · Cited by 153
Brøns, C., & Grunnet, L. G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0488 · Cited by 110
Papathanasiou, G., Zerva, E., Zacharis, I., Παπανδρέου, Μ., Papageorgiou, E. G., Tzima, C., Georgakopoulos, D., & Evangelou, A. M. (2015) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401509010005 · Cited by 135
Sondrup, N., Termannsen, A.-D., Eriksen, J. N., Hjorth, M. F., Færch, K., Klingenberg, L., & Quist, J. S. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101594 · Cited by 92
Ectopic fat accumulation in the pancreas and its biomarkers: A systematic review and meta‐analysis
Singh, R. G., Yoon, H. D., Poppitt, S. D., Plank, L. D., & Petrov, M. S. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2918 · Cited by 102
Multiorgan insulin sensitivity in lean and obese subjects
Conte, C., Fabbrini, E., Kars, M., Mittendorfer, B., Patterson, B. W., & Klein, S. (2012) · Diabetes Care · doi:10.2337/dc11-1951 · Cited by 99
“Most obese people do not have impaired glucose tolerance or diabetes, so our group represents the majority of the obese population (4).”
BackgroundGower, B. A., & Goss, A. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195065 · Cited by 98
“These observations suggest that carbohydrate restriction reduces insulin secretion, which may facilitate fat mobilization (33), particularly from the intra-abdominal area, a depot associated with metabolic dysfunction that is enlarged in individuals with T2D (34, 35).”
BackgroundGluteofemoral Adipose Tissue Plays a Major Role in Production of the Lipokine Palmitoleate in Humans
Pinnick, K. E., Neville, M. J., Fielding, B. A., Frayn, K. N., Karpe, F., & Hodson, L. (2012) · Diabetes · doi:10.2337/db11-1810 · Cited by 96
Self-citationRegulatory microRNAs in Brown, Brite and White Adipose Tissue
Gharanei, S., Shabir, K., Brown, J. E. P., Weickert, M. O., Barber, T. M., Kyrou, I., & Randeva, H. S. (2020) · Cells · doi:10.3390/cells9112489 · Cited by 106
“When energy is required by other organs/tissues, these lipids are hydrolyzed and FFA are released back into the circulation [12].”
BackgroundImpact of probiotics and prebiotics targeting metabolic syndrome
Xavier-Santos, D., Bedani, R., Lima, E. D., & Saad, S. M. I. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103666 · Cited by 107
“Moreover, insulin resistance is also related to the accumulation of lipids in insulin-sensitive tissues, so-called ectopic fat deposition (Karpe, Dickmann, & Frayn, 2011; Yki-Järvinen, 2002), mediated by modulation of the function/expression of the transporter proteins (Holloway, Luiken, Glatz, Spriet, & Bonen, 2008;…”
BackgroundDeterminants of VLDL-triglycerides production
Nielsen, S., & Karpe, F. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283544956 · Cited by 94
“However, the first part of this argument has recently been questioned [29] and it is important to consider the possibility that poorly”
BackgroundSelf-citationSexual dimorphism in white and brown adipose tissue with obesity and inflammation
Bloor, I. D., & Symonds, M. E. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.02.007 · Cited by 108
Free fatty acids sensitize dendritic cells to amplify TH1/TH17‐immune responses
Stelzner, K., Herbert, D., Popkova, Y., Lorz, A., Schiller, J., Gericke, M. T., Klöting, N., Blüher, M., Franz, S., Simon, J. C., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546263 · Cited by 101
Luo, Z., Xu, W., Zhang, Y., Di, L., & Shan, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105088 · Cited by 104
Effects of LPS and dietary free fatty acids on MCP-1 in 3T3-L1 adipocytes and macrophages in vitro
Cullberg, K. B., Larsen, J. Ø., Pedersen, S. B., & Richelsen, B. (2014) · Nutrition and Diabetes · doi:10.1038/nutd.2014.10 · Cited by 103
Overnutrition, Ectopic Lipid and the Metabolic Syndrome
Grundy, S. M. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000155 · Cited by 117
Early-life exposure to perfluoroalkyl substances and childhood metabolic function
Fleisch, A. F., Rifas-Shiman, S. L., Mora, A. M., Calafat, A. M., Ye, X., Luttmann-Gibson, H., Gillman, M. W., Oken, E., & Sagiv, S. K. (2017) · Environmental Health Perspectives · doi:10.1289/ehp303 · Cited by 91
“A growing body of literature suggests that PFAS exposure may contribute to metabolic dysfunction (Audouze et al. 2013; U.S. EPA 2013) through up-regulation of fatty acid oxidation pathways (Guruge et al. 2006; Hu et al. 2005) and concomitantly increased oxidative stress (Karpe et al. 2011).”
BackgroundLactate homeostasis is maintained through regulation of glycolysis and lipolysis
Lee, W. D., Weilandt, D., Liang, L., MacArthur, M. R., Jaiswal, N., Ong, O. C., Mann, C. G., Chu, Q., Hunter, C. J., Ryseck, R.-P., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2024.12.009 · Cited by 96
Jocken, J. W. E., Goossens, G. H., Boon, H., Mason, R. R., Essers, Y., Havekes, B., Watt, M. J., van Loon, L. J., & Blaak, E. E. (2013) · Diabetologia · doi:10.1007/s00125-013-2995-9 · Cited by 87
“This increased lipid supply to SM may promote ectopic fat accumulation [10].”
BackgroundLessard, J., Laforest, S., Pelletier, M., Leboeuf, M., Blackburn, L., & Tchernof, A. (2014) · Adipocyte · doi:10.4161/adip.29385 · Cited by 90
“198 adipocyte Volume 3 Issue 3 lipid storage capacity of adipose tissue.(15,16) Consistent with this notion, Arner and collaborators showed that reduced generation of new adipocytes (low hyperplasia) was related to hypertrophy of mature adipocytes, a phenomenon that was also correlated with insulin values and insulin…”
BackgroundFree Fatty Acids and Their Metabolism Affect Function and Survival of Podocytes
Sieber, J., & Jehle, A. W. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00186 · Cited by 93
Mohamed, I. N., Ishrat, T., Fagan, S. C., & El-Remessy, A. B. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6126 · Cited by 88
“FFA plasma levels are relatively higher in obesity and are one of the major factors for inducing obesity and metabolic syndrome-associated inflammation and insulin resistance (12, 13, 34, 59).”
Membrane lipid alterations in the metabolic syndrome and the role of dietary oils
Perona, J. S. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.04.015 · Cited by 96
Choi, S., Kim, E. S., Koh, M., Lee, S., Lim, D., Yang, Y. R., Jang, H., Seo, K., Min, S., Lee, I. H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566794 · Cited by 89
“Therefore, adipose tissue lipolysis is a major target for anti-diabetes drug development (37, 38).”
BackgroundTang, D., Liu, L., Ajiakber, D., Ye, J., Xu, J., Xin, X., & Aisa, H. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00586 · Cited by 93
Linoleic acid rescues microglia inflammation triggered by saturated fatty acid
Tu, T. H., Kim, H., Yang, S., Kim, J. K., & Kim, J. G. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.047 · Cited by 84
Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion
Mizgier, M. L., Casas, M., Contreras‐Ferrat, A., Llanos, P., & Galgani, J. E. (2014) · Obesity Reviews · doi:10.1111/obr.12166 · Cited by 82
“(28) recently compiled a large set of studies and found no evidence to support the notion that obesity is accompanied by increased fasting blood FFA concentration, a physiological state of high lipolytic activity.”
BackgroundEffects of dyslipidaemia on monocyte production and function in cardiovascular disease
Rahman, M. S., Murphy, A. J., & Woollard, K. J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.34 · Cited by 92
Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
D’Adamo, E., Guardamagna, O., Chiarelli, F., Bartuli, A., Liccardo, D., Ferrari, F., & Nobili, V. (2015) · International Journal of Endocrinology · doi:10.1155/2015/912047 · Cited by 100
Park, E., Edirisinghe, I., Wei, H., Vijayakumar, L. P., Banaszewski, K., Cappozzo, J. C., & Burton‐Freeman, B. M. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500845 · Cited by 91
Fisk, H. L., West, A. L., Childs, C. E., Burdge, G. C., & Calder, P. C. (2014) · Journal of Visualized Experiments · doi:10.3791/51445 · Cited by 89
Zhang, L., Bahl, M. I., Roager, H. M., Fonvig, C. E., Hellgren, L. I., Frandsen, H. L., Pedersen, O., Holm, J.-C., Hansen, T., & Licht, T. R. (2017) · The ISME Journal · doi:10.1038/ismej.2016.151 · Cited by 84
“Although mice in Control groups 1 and 2 did not differ significantly in weight gain (Figure 2e), the latter group had lower insulin resistance, as shown by significantly lower levels of HOMA-IR, fasting insulin, as well as of two circulating lipids closely related to insulin resistance, NEFA and triglycerides (Julius,…”
BackgroundWang, Y., Zhang, L., Teng, Y., Zhang, J., Yang, L., Li, J., Lai, J., Zhao, Y., & Wu, Y. (2018) · Journal of Environmental Sciences · doi:10.1016/j.jes.2018.03.016 · Cited by 82
Williams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 87
Xu, P., Hong, F., Wang, J., Cong, Y., Dai, S., Wang, S., Wang, J., Jin, X., Wang, F., Liu, J., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.019 · Cited by 84
“The NEFA in serum is almost entirely derived from the hydrolysis of TG, which is present at high levels in fatty food and adipose tissue (Karpe et al., 2011), and serumendotoxin ismainly produced by gutmicrobiota (Cani et al.”
BackgroundInfluentialInsulin-stimulated glucose uptake in healthy and insulin-resistant skeletal muscle
Deshmukh, A. S. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0041 · Cited by 92
A MicroRNA Linking Human Positive Selection and Metabolic Disorders
Wang, L., Sinnott-Armstrong, N., Wagschal, A., Wark, A. R., Camporez, J. P., Perry, R. J., Ji, F., Sohn, Y., Oh, J. D., Wu, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.017 · Cited by 91
“In addition, anti-miR-128-1 treatment also manifested increased WAT insulin sensitivity as reflected by increased 2-deoxyglucose uptake in WAT (Figure 4F) and increased suppression of non-esterified fatty acid (NEFA) release from WAT (Figure 4H) during the clamp, both of which are hallmarks of T2D and contributors to…”
Background60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years
Murray, P. G., Higham, C., & Clayton, P. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0120 · Cited by 86
Azab, S. M., Ly, R., & Britz‐McKibbin, P. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05054 · Cited by 84
Díez‐Fernández, A., Sánchez‐López, M., Mora‐Rodríguez, R., Notario‐Pacheco, B., Torrijos-Niño, C., & Martínez‐Vizcaíno, V. (2013) · Diabetes Care · doi:10.2337/dc13-0416 · Cited by 85
“Although it has not been fully elucidated whether adiposity causes insulin resistance (32), all four cardiometabolic risk factors have shown a trend toward an increase in prevalence as BMI increases (33–36), and prospective data suggest that the most important risk factor for MetS is the rate of increase in BMI in you…”
Allosteric modulation of zinc speciation by fatty acids
Barnett, J. P., Blindauer, C. A., Kassaar, O., Khazaipoul, S., Martin, E. M., Sadler, P. J., & Stewart, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.05.028 · Cited by 78
Kuwabara, W. M. T., Panveloski-Costa, A. C., Yokota, C. N. F., Pereira, J. N. B., Filho, J. M., Torres, R. P., Hirabara, S. M., Curi, R., & Alba‐Loureiro, T. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189622 · Cited by 85
Hong, S., Song, W., Zushin, P. H., Liu, B., Jedrychowski, M. P., Mina, A. I., Deng, Z., Čabarkapa, D., Hall, J. A., Palmer, C. J., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.012 · Cited by 78
“(H) Effect of MEKi on adipose tissue explants from mouse inguinal WAT in a glycerol release assay (I) Core body temperature measured by subcutaneous telemetry probes and (J) NEFA in mice treated with saline (Control), ATGL inhibitor (ATGLi) or MEKi during a 4 C cold temperature challenge.”
BackgroundInfluentialWeighing In on mTOR Complex 2 Signaling: The Expanding Role in Cell Metabolism
Luo, Y., Xu, W., Li, G., & Cui, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7838647 · Cited by 75
“Although elevated FFA is not necessarily associated with insulin resistance [81], increasing adipose lipolysis could increase hepatic glucose production and cause insulin resistance [82].”
BackgroundBiochemical Markers of Aging for Longitudinal Studies in Humans
Engelfriet, P. M., Jansen, E. H. J. M., Picavet, H. S. J., & Dolle, M. E. T. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs011 · Cited by 72
Xu, E., Schwab, M. G., & Marette, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9282-4 · Cited by 85
Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice
Liu, Q., Liu, Y., Li, F., Gu, Z., Liu, M., Shao, T., Zhang, L., Zhou, G., Pan, C., He, L., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108256 · Cited by 80
Lipid metabolism disorder in diabetic kidney disease
Han, Y.-Z., Du, B., Zhu, X., Wang, Y., Zheng, H., & Liu, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1336402 · Cited by 85
“Phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphocholine (PC) and sphingomyelin (SM) were signi fi cantly altered (73, 74).”
BackgroundHodson, L., Banerjee, R., Rial, B., Arlt, W., Adiels, M., Boren, J., Marinou, K., Fisher, C., Mostad, I. L., Stratton, I. M., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002258 · Cited by 74
“3 (35-63) for lean and abdominally obese women respectively.”
BackgroundSelf-citationBhakkiyalakshmi, E., Sireesh, D., Sakthivadivel, M., Sivasubramanian, S., Gunasekaran, P., & Ramkumar, K. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.02.054 · Cited by 73
“Increased β-oxidation of fatty acids promotes acetyl CoA synthesis and cholesterol levels during diabetes (Karpe et al., 2011).”
BackgroundTanaka, Y., Nagoshi, T., Takahashi, H., Oi, Y., Yoshii, A., Kimura, H., Ito, K., Kashiwagi, Y., Tanaka, T. D., & Yoshimura, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101411 · Cited by 74
“This might be because the blood samples were collected after a substantial period of fasting, which resulted in the stimulation of lipolysis in adipose tissues even in the NFD-fed mice [39].”
BackgroundPlasma levels of free fatty acids correlate with type 2 diabetes mellitus
Spiller, S., Blüher, M., & Hoffmann, R. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13449 · Cited by 83
Chen, J.-W., Kong, Z., Tsai, M., Lo, C., Ho, C., & Lai, C. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.01.005 · Cited by 78
“Elevated FFAs in obese individuals is considered a critical pathogenic factor of metabolic diseases, including NAFLD and diabetes [2,3,34].”
BackgroundZaoui, M., Morel, M., Ferrand, N., Fellahi, S., Bastard, J., Lamazière, A., Larsen, A. K., Béréziat, V., Atlan, M., & Sabbah, M. (2019) · Cancers · doi:10.3390/cancers11122012 · Cited by 79
“Therefore, BMI alone may not be an accurate indicator of fatty acid levels [52].”
BackgroundLopez-Legarrea, P., de la Iglesia, R., Crujeiras, A. B., Pardo, M., Casanueva, F. F., Zulet, M. A., & Martinez, J. A. (2014) · Nutrition & Diabetes · doi:10.1038/nutd.2014.7 · Cited by 60
A human model of dietary saturated fatty acid induced insulin resistance
Koška, J., Ozias, M. K., Deer, J., Kurtz, J., Salbe, A. D., Harman, S. M., & Reaven, P. D. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.015 · Cited by 75
Cross, T.-W., Heden, T. D., Morris, E. M., Fritsche, K. L., Vieira‐Potter, V. J., & Thyfault, J. P. (2015) · Lipids · doi:10.1007/s11745-015-4061-5 · Cited by 79
“Moreover, some data suggest that obesity is not always linked with elevated serum FFA [29].”
BackgroundArmstrong, M. J., Hazlehurst, J. M., Hull, D., Guo, K., Borrows, S., Yu, J., Gough, S. C., Newsome, P. N., & Tomlinson, J. W. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12272 · Cited by 69
“Previous studies in NASH patients have solely relied on circulating NEFA to provide estimates of adipose IR [8,9,12,13,32], which are more reflective of wholebody lipolysis, rather that depot-specific [37].”
Veum, V. L., Laupsa‐Borge, J., Eng, Ø., Rostrup, E., Larsen, T. H., Nordrehaug, J. E., Nygard, O. K., Sagen, J. V., Gudbrandsen, O. A., Dankel, S. N., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.123463 · Cited by 81
Slupsky, C. M., He, X., Hernell, O., Andersson, Y., Rudolph, C. D., Lönnerdal, B. L., & West, C. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-03975-4 · Cited by 72
“It is known that high circulating NEFA activates ketogenesis 33 .”
BackgroundAspalathin improves glucose and lipid metabolism in 3T3‐L1 adipocytes exposed to palmitate
Mazibuko, S. E., Joubert, E., Johnson, R., Louw, J., Opoku, A. R., & Muller, C. J. F. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500258 · Cited by 75
Ng, J. M., Azuma, K., Kelley, C., Pencek, R., Radikova, Z., Laymon, C., Price, J., Goodpaster, B. H., & Kelley, D. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00282.2012 · Cited by 67
“(20) have advocated that increased AT mass does not necessarily lead to increased FFA.”
BackgroundWiklund, P., Zhang, X., Pekkala, S., Autio, R., Kong, L., Yang, Y., Keinanen-Kiukaanniemi, S. M., Alén, M., & Cheng, S. (2016) · Scientific Reports · doi:10.1038/srep24540 · Cited by 77
Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism
Nagarajan, S. R., Cross, E., Sanna, F., & Hodson, L. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003761 · Cited by 71
“However, Karpe et al.(37) elegantly demonstrated that elevated NEFA concentrations are not explained by an increased adipose tissue mass as the NEFA release per kilogram of adipose tissue mass is reduced with obesity.”
InfluentialAdipose triglyceride lipase activity is inhibited by long-chain acyl-coenzyme A
Nagy, H. M., Paar, M., Heier, C., Moustafa, T., Hofer, P., Haemmerle, G., Lass, A., Zechner, R., Oberer, M., & Zimmermann, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.01.005 · Cited by 66
Hellmuth, C., Demmelmair, H., Schmitt, I., Peißner, W., Blüher, M., & Koletzko, B. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074927 · Cited by 66
“In previous studies sAT [40,41] or vAT [39] have been claimed to be the major source of pNEFA, while our correlation analyses did not point towards a clearly higher contribution of sAT or vAT.”
ResultWong, T. H. T., & Louie, J. C. Y. (2016) · Starch - Stärke · doi:10.1002/star.201600205 · Cited by 69
“with the expansion in the mass of adipose tissues [42].”
BackgroundAl‐Sulaiti, H., Diboun, I., Banu, S., Al-Emadi, M., Amani, P., Harvey, T. M., Dömling, A. S. S., Latiff, A. A., & Elrayess, M. A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1548-x · Cited by 70
“IS, IR and T2DM specific differences Systemic levels of fatty acid increase with obesity and T2DM, perhaps as a result of insulin resistance of adipose tissue and subsequent increased lipolysis; although in some obese individuals, fatty acid release from adipose tissues is reduced per kg fat in order to normalize plas…”
BackgroundPlasma long-chain free fatty acids predict mammalian longevity
Jové, M., Naudí, A., Aledo, J. C., Cabré, R., Ayala, V., Portero‐Otín, M., Barja, G., & Pamplona, R. (2013) · Scientific Reports · doi:10.1038/srep03346 · Cited by 65
Pereira, M. J., Skrtic, S., Katsogiannos, P., Abrahamsson, N., Sidibeh, C. O., Dahgam, S., Månsson, M., Risérus, U., Kullberg, J., & Eriksson, J. W. (2016) · Metabolism · doi:10.1016/j.metabol.2016.09.008 · Cited by 71
GPR120: a critical role in adipogenesis, inflammation, and energy metabolism in adipose tissue
Song, T., Yang, Y., Zhou, Y., Wei, H., & Peng, J. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2492-2 · Cited by 75
Gydesen, S., Hjuler, S. T., Freving, Z., Andreassen, K. V., Sonne, N., Hellgren, L. I., Karsdal, M. A., & Henriksen, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13723 · Cited by 63
“The lowering of insulin levels could be attributed to the lack of improvement in glucose tolerance when compared with the improvement observed in KBP-089-treated rats, which would have been likely after a significant weight loss (Horton and Hill, 2001; Lafontan and Langin, 2009; Karpe et al., 2011).”
Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles
Vesterdal, L. K., Danielsen, P. H., Folkmann, J. K., Jespersen, L. F., Aguilar-Pelaez, K., Roursgaard, M., Loft, S. H., & Möller, P. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.001 · Cited by 66
Liang, X., Yee, S. W., Chien, H., Chen, E. C., Luo, Q., Zou, L., Piao, M., Mifune, A., Chen, L., Calvert, M., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2002907 · Cited by 66
“Furthermore, fasting free fatty acid levels were lower in the plasma of Oct1 mice (Fig 6E), which may reflect the lower rates of lipolysis in adipose tissue [56].”
BackgroundAgius, R., Pace, N. P., & Fava, S. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3725 · Cited by 74
The effect of short‐term overfeeding on serum lipids in healthy humans
Heilbronn, L. K., Coster, A. C. F., Campbell, L. V., Greenfield, J. R., Lange, K. M., Christopher, M., Meikle, P. J., & Samocha‐Bonet, D. (2013) · Obesity · doi:10.1002/oby.20508 · Cited by 67
“(NEFA) by infusion of lipid emulsion induce insulin resistance in humans (5).”
BackgroundLee, Y., Hu, S., Park, Y., & Lee, J. (2019) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2019.24.2.103 · Cited by 67
“However, when the adipose tissue is insulin-resistant, an excessive amount of FFAs are released from adipocytes due to dysregulated lipolysis (Pappachan et al., 2017; Karpe et al., 2011).”
BackgroundKanwal, S., Aliya, S., & Xin, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.558874 · Cited by 65
Obesity and Insulin Resistance: An Abridged Molecular Correlation
Mukherjee, B., Hossain, C. M., Mondal, L., Paul, P., & Ghosh, M. K. (2013) · Lipid Insights · doi:10.4137/lpi.s10805 · Cited by 79
Zhou, X., Liu, W., Gu, M., Zhou, H., & Zhang, G. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1051-6 · Cited by 65
“muscle and adipose tissue and hepatic glucose production [1].”
BackgroundIyer, A., Lim, J., Poudyal, H., Reid, R. C., Suen, J. Y., Webster, J. A., Prins, J. B., Whitehead, J. P., Fairlie, D. P., & Brown, L. (2012) · Diabetes · doi:10.2337/db11-1179 · Cited by 64
“Contrary to current opinion, increasing or normalizing lipolysis as a pharmaceutic strategy or elevating plasma free fatty acids in obese subjects may not necessarily translate into metabolic dysfunction or insulin resistance (47).”
BackgroundBaldi, S., Menicatti, M., Nannini, G., Niccolai, E., Russo, E., Ricci, F., Pallecchi, M., Romano, F., Pedone, M., Poli, G., et al. (2021) · Nutrients · doi:10.3390/nu13030742 · Cited by 63
“However, a different study reported contrasting data, documenting higher serum FFAs in women with respect to men with obesity [68].”
Thota, P., Pérez-López, F. R., Benites-Zapata, V. A., Pasupuleti, V., & Hernández, A. V. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1273897 · Cited by 61
“the development of insulin resistance [46].”
Sergi, D., Morris, A. C., KAHN, D. E., McLean, F. H., Hay, E. A., Kubitz, P., MacKenzie, A., Martinoli, M., Drew, J. E., & Williams, L. M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1501533 · Cited by 64
Kilany, O. E., Abdelrazek, H. M. A., Aldayel, T. S., Abdo, S., & Mahmoud, M. M. A. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.06.026 · Cited by 70
Transcriptional Cofactor TBLR1 Controls Lipid Mobilization in White Adipose Tissue
Rohm, M., Sommerfeld, A., Strzoda, D., Jones, A., Sijmonsma, T., Rudofsky, G., Wolfrum, C., Sticht, C., Gretz, N., Zeyda, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.010 · Cited by 67
“…function, supporting the notion that a decreased release of FFA from adipocytes per se—and hence elevated adipose tissue TG accumulation—does not necessarily predict an improvement in systemic insulin sensitivity as already highlighted by a number of studies in humans (Karpe et al., 2011).”
InfluentialLiang, H., Tantiwong, P., Sriwijitkamol, A., Shanmugasundaram, K., Mohan, S., Espinoza, S., DeFronzo, R. A., Dubé, J. J., & Musi, N. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.247510 · Cited by 59
“Obese non-diabetic subjects also are reported to have an increased plasma FFA concentration, although the magnitude of the increase is less severe than that seen in T2DM individuals (∼70 μM higher than lean individuals) (Karpe et al. 2011).”
BackgroundBajpeyi, S., Covington, J. D., Taylor, E. M., Stewart, L. K., Galgani, J. E., & Henagan, T. M. (2017) · Endocrinology · doi:10.1210/en.2017-00051 · Cited by 66
Adipose tissue oxygenation: Effects on metabolic function
Hodson, L. (2014) · Adipocyte · doi:10.4161/adip.27114 · Cited by 58
Singh, M., Kaur, R., Lee, M.-J., Pickering, R. T., Sharma, V. M., Puri, V., & Kandror, K. V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c114.563080 · Cited by 58
“Fortunately, fasting plasma FA levels demonstrate a much more modest increase and are largely unrelated to body fat mass (48), although the mechanisms of this compensation are not known.”
BackgroundMain characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes
Teixeira, T. F., Alves, R. D. M., Moreira, A. P. B., & Pelúzio, M. D. C. G. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu007 · Cited by 68
Exercise and Health-Related Risks of Physical Deconditioning After Spinal Cord Injury
MAHER, J. L., McMillan, D. W., & Nash, M. S. (2017) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci2303-175 · Cited by 67
Increased susceptibility of post-weaning rats on high-fat diet to metabolic syndrome
Cheng, H. S., Ton, S. H., Phang, S. C. W., Tan, J. B. L., & Kadir, K. A. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.10.002 · Cited by 67
“reviewed a number of clinical data and concluded that the causal relationship of increased systemic FFA and insulin resistance may not always be true [40].”
BackgroundRelationships between muscle mass, strength and regional bone mineral density in young men
Sutter, T., Toumi, H., Valéry, A., Hage, R. E., Pinti, A., & Lespessailles, É. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213681 · Cited by 67
Halabitska, I., Бабинец, Л. С., Oksenych, V., & Kamyshnyi, O. (2024) · Biomedicines · doi:10.3390/biomedicines12081630 · Cited by 60
“Several studies indicate that the breakdown of AT triglycerides is highly sensitive to insulin [42,43].”
BackgroundMeyer, B. J., Stewart, F. M., Brown, E. A., Cooney, J., Nilsson, S., Olivecrona, G., Ramsay, J. E., Griffin, B. A., CASLAKE, M. J., & Freeman, D. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3481 · Cited by 58
“Plasma NEFA levels were stable over pregnancy, as has been observed for nonpregnant obesity, insulin resistance, and well-controlled type 2 diabetes (38).”
BackgroundHigh fat diet disrupts endoplasmic reticulum calcium homeostasis in the rat liver
Wires, E. S., Trychta, K. A., Bäck, S., Sulima, A., Rice, K. C., & Harvey, B. K. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.023 · Cited by 58
“Elevated levels of circulating FFA are a hallmark of obesity and are often observed as a result of insufficient lipid storage by adipocytes, thus leading to the accumulation of lipids in non-adipose tissue, such as the liver.(15) Collectively, these data indirectly implicate ER calcium dysregulation because of impaire…”
BackgroundCiregia, F., Bugliani, M., Ronci, M., Giusti, L., Boldrini, C., Mazzoni, M. R., Mossuto, S., Grano, F., Cnop, M., Marselli, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13908-w · Cited by 61
Metadata
- Authors
- Karpe, F., Dickmann, J. R., & Frayn, K. N.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Karpe, Fredrik
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-09-16
- Volume
- 60
- Issue
- 10
- Pages
- 2441-2449
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3178283
- OpenAlex
- W2152688545
- Cited by
- 896
- References
- 91
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 41 · 2023: 45 · 2022: 73 · 2021: 72 · 2020: 76 · 2019: 74 · 2018: 68 · 2017: 85 · 2016: 76 · 2015: 78 · 2014: 57 · 2013: 53 · 2012: 31
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- University of Oxford
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- free fatty acids, obesity, insulin resistance, adipose tissue lipolysis, fatty acid mobilization, plasma albumin binding, triacylglycerol mobilization, insulin signaling
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Fatty Acids, Nonesterified, Humans, Insulin Resistance, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.